日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Sequential hepatectomy for hepatocellular carcinoma with inadequate future-liver-remnant after portal vein ligation in combination with apatinib plus camrelizumab (PLACES): a single-arm prospective pilot study

门静脉结扎后肝脏残余量不足的肝细胞癌序贯肝切除术联合阿帕替尼和卡瑞利珠单抗治疗（PLACES）：一项单臂前瞻性试点研究

期刊:Hepatobiliary Surgery and Nutrition
影响因子:7.8
doi:10.21037/hbsn-24-363
Zeng, Zhiming; Huang, Huasheng; Zhu, Guangzhi; Zeng, Jie; Ye, Xinping; Su, Hao; He, Yongfei; Jiang, Yanfeng; Su, Ming; Liu, Cuizhen; Han, Chuangye; Liao, Xiwen; Mo, Ning; Ma, Fuchao; Li, Tianman; Zhou, Xin; Liao, Jinyuan; Lv, Zili; Luo, Weifei; Wen, Zhang; Xu, Banghao; Chen, Bin; Peng, Minhao; Ma, Jie; Peng, Tao
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Extrachromosomal DNA drives molecular and clinical heterogeneity in hepatocellular carcinoma: a multi-omics analysis and prognostic model development.

染色体外DNA驱动肝细胞癌的分子和临床异质性：多组学分析和预后模型开发。

期刊:Human Genomics
影响因子:4.3
doi:10.1186/s40246-026-00927-w
Huang Kai, Zhang Guangquan, Hu Shuai, He Yongfei, Zhai Hang, Xu Junming, Wang Jicai, Hong Shengjie, Wu Fenfang, Shi Xianjie
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

A Noninvasive Predictive Model of Portal Hypertension in Patients with HCC Based on Clinical Features and Intra- and Peritumoral Pre-Fusion Radiomic Features

基于临床特征和肿瘤内及肿瘤周围融合前放射组学特征的肝细胞癌患者门静脉高压无创预测模型

期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S596500
Gao, Qiang; Zhu, Chunyi; Chen, Meifeng; Mo, Shutian; He, Yongfei; Huang, Ketuan; Liao, Yuan; Liang, Tianyi; Han, Chuangye; Peng, Tao
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

LPCAT1 as a prognostic biomarker and risk indicator for hepatocellular carcinoma: insights into genes related to lipid metabolism

LPCAT1作为肝细胞癌的预后生物标志物和风险指标：脂质代谢相关基因的启示

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2026.1707270
Zhai, Hang; Wang, Jicai; He, Yongfei; Hong, Shengjie; Huang, Kai; Hu, Shuai; Xu, Junming; Hao, Shuang; Zhang, Guangquan; Shi, Xianjie
细胞生物学
肿瘤
肿瘤免疫
代谢
发表日期：2026
文献求助 收藏

Lycii radicis cortex alleviates fibrosis in hiPSC-derived multilineage hepatic organoids via the cAMP-PKA pathway

枸杞根皮通过 cAMP-PKA 通路减轻 hiPSC 来源的多系肝类器官的纤维化

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1730255
Xu, Junming; Sang, Xiaopu; He, Yongfei; Ke, Jie; Xu, Jiasen; Liu, Tanbin; Wang, Jicai; Zhai, Hang; Chen, Xiaoni; Shi, Xianjie; Wu, Fenfang
3D/类器官
信号转导
GPCR/Calcium/cAMP
PKA
发表日期：2025
文献求助 收藏

2-Dodecyl-6-methoxycyclohexa-2,5-dien-1,4-dione alleviates liver fibrosis and improves intestinal flora and bile acid metabolism.

2-十二烷基-6-甲氧基环己-2,5-二烯-1,4-二酮可缓解肝纤维化，改善肠道菌群和胆汁酸代谢

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1581138
He Yongfei, Hoa Pham Thi Thai, Xu Junming, Hong Shengjie, Wang Jicai, Zhai Hang, Tao Qiang, Li Ruixi, Zhang Guangquan, Shi Xianjie
代谢
肠道菌群
发表日期：2025
文献求助 收藏

Atorvastatin negatively regulates MAPK pathway in vitro to inhibit proliferation, migration, and invasion of hepatocellular carcinoma cells

阿托伐他汀在体外通过负调控MAPK通路抑制肝细胞癌细胞的增殖、迁移和侵袭。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-25040-1
Meng, Yuhua; Mo, Linfang; Liang, Tianyi; Mo, Shutian; Han, Chuangye; He, Yongfei
肿瘤
肿瘤免疫
信号转导
MAPK/ERK
细胞生物学
发表日期：2025
文献求助 收藏

Predictive value of intra-hepatectomy ICGR15 of the remnant liver for post-hepatectomy liver failure in hemi-hepatectomy: a prospective study

肝切除术后残余肝脏的肝内ICGR15对肝切除术后肝功能衰竭的预测价值：一项前瞻性研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14296-5
Liang, Tianyi; He, Yongfei; Mo, Shutian; Liao, Yuan; Huang, Ketuan; Gao, Qiang; Shen, Xiaoqiang; Yang, Chengkun; Liao, Xiwen; Qin, Wei; Zhu, Guangzhi; Su, Hao; Ye, Xinping; Han, Chuangye; Peng, Tao
肝衰竭
发表日期：2025
文献求助 收藏

Application of propensity score matching in prognostic analysis of portal hypertension in hepatocellular carcinoma patients

倾向评分匹配在肝细胞癌患者门静脉高压预后分析中的应用

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1644629
Gao, Qiang; Zhu, Chunyi; Chen, Meifeng; Mo, Shutian; He, Yongfei; Huang, Ketuan; Liao, Yuan; Liang, Tianyi; Han, Chuangye; Peng, Tao
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Ansofaxine Hydrochloride inhibits hepatocellular carcinoma growth and enhances targeted therapy through the EGFR/MAPK pathway.

盐酸安索法辛通过 EGFR/MAPK 通路抑制肝细胞癌的生长并增强靶向治疗

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1523570
He Yongfei, Tao Qiang, Mo Shutian, Chen Meifeng, Wang Jicai, Zhai Hang, Hong Shengjie, Gao Qiang, Zhang Guangquan, Han Chuangye, Shi Xianjie
细胞生物学
MAPK/ERK
EGFR
肿瘤免疫
发表日期：2025
文献求助 收藏